Detailed answers about KENSINGTON REGENERATIVE CLINIC LIMITED, including incorporation, status, business activity, and accounts information.
When was KENSINGTON REGENERATIVE CLINIC LIMITED founded?
KENSINGTON REGENERATIVE CLINIC LIMITED was officially incorporated on 27 April 2026 and is registered under company number 17184554. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KENSINGTON REGENERATIVE CLINIC LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KENSINGTON REGENERATIVE CLINIC LIMITED?
KENSINGTON REGENERATIVE CLINIC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KENSINGTON REGENERATIVE CLINIC LIMITED do?
KENSINGTON REGENERATIVE CLINIC LIMITED operates in the following sectors: 86210 - General medical practice activities, 86220 - Specialists medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is KENSINGTON REGENERATIVE CLINIC LIMITED's registered address?
The registered office address of KENSINGTON REGENERATIVE CLINIC LIMITED is Unimix House, Platinum Suite, Abbey Road, London, United Kingdom, NW10 7TR. This is the official address filed with Companies House for legal and statutory correspondence.
Is KENSINGTON REGENERATIVE CLINIC LIMITED financially stable?
Financial accounts for KENSINGTON REGENERATIVE CLINIC LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.